Principal investigator John Harrison, PsyD candi

Principal investigator John Harrison, PsyD candidate at the California Institute of Integral Studies (CIIS), received a letter from the Human Research Review Committee of CIIS granting final approval for the MAPS-sponsored ibogaine outcome protocol. John can now start our investigation into the short and longer-term outcomes of ibogaine treatment for opiate addiction.

The study will follow 30 patients who undergo ibogaine therapy at the Pangea Biomedics Ibogaine Association in Playas De Tijuana, Mexico for one year after their treatment.
In order to gather quantitative data about outcome, John will administer the Addiction Severity Index (ASI) on a monthly basis to each subject during an approximately one-hour phone conversation. Interviews with significant others will also be conducted, as a way to try to verify the accuracy of subject self-reports. Valerie Mojeiko, MAPS Director of Operations and Clinical Research, met with John Harrison to conduct a study initiation visit on October 9.